IBM Watson is a computer system that can respond to inquiries posed in natural language and learn from its responses. WellPoint aims for this technology to support physicians in evaluating evidence-based cancer treatment options, thus improving the quality of care.
IU Simon Cancer Center will provide clinical expertise to build Watson’s database of information, which is also based on scientific and healthcare data. The cancer center will recommend clinical content and help evaluate and test specific tools. The center will also work with its informatics partner, the Regenstrief Institute, and WellPoint’s clinical experts to determine how to optimize the use of Watson in a clinical environment.
IU Simon Cancer Center will be among the first organizations to pilot WellPoint’s healthcare solutions, which the company may release later this year, according to the release.
More Articles on Hospital Oncology and IBM Watson:
Memorial Sloan-Kettering in NY Works With IBM Watson to Improve Oncology Care
WellPoint, Cedars-Sinai in Los Angeles Partner on Solutions Using Watson Technology
From Jeopardy to Healthcare: WellPoint Strikes Deal With IBM Over Watson
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
